Effects of Gum Arabic Ingestion on Hormonal and Metabolic Changes in Patients With Polycystic Ovary Syndrome (GA&PCO)
Effects of Gum Arabic Ingestion on Hormonal and Metabolic Changes in Patients With Polycystic Ovary Syndrome: Two Arm Randomized Double Blind Placebo Controlled Study
Sponsor: Lamis Kaddam
Listed as NCT04215380, this NA trial focuses on Polycystic Ovary Syndrome and remains ongoing. Sponsored by Lamis Kaddam, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Enrolling By Invitation NA
-
Feb 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lamis Kaddam
For direct contact, visit the study record on ClinicalTrials.gov .